The comparison of miR-155 with computed tomography and computed tomography plus serum amyloid A protein in staging rectal cancer

Journal of Surgical Research

Volumn 193, Issue 2, 2015, Pages 764-771

  Yang, Yun ^a   Tang, Tian ^a   Peng, Wei ^b   Xia, Lin ^a   Wang, Xiaodong ^a   Duan, Baofeng ^a   Shu, Ye ^a  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

CT; microRNA; miR 155; N stage; Rectal cancer; SAA

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; MICRORNA 155; SERUM AMYLOID A; MICRORNA; MIRN155 MICRORNA, HUMAN;

ADULT; ARTICLE; CANCER PATIENT; CANCER STAGING; CANCER TISSUE; CLINICAL ARTICLE; COMPARATIVE STUDY; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HUMAN; HUMAN TISSUE; LYMPH NODE; LYMPH NODE METASTASIS; MALE; PREOPERATIVE EVALUATION; PROTEIN EXPRESSION; RECTUM CANCER; RECTUM CARCINOMA; SENSITIVITY AND SPECIFICITY; AGED; CARCINOMA; CLINICAL TRIAL; FEASIBILITY STUDY; METABOLISM; MIDDLE AGED; PATHOLOGY; RADIOGRAPHY; RECTUM TUMOR;

AGED; CARCINOMA; FEASIBILITY STUDIES; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MICRORNAS; MIDDLE AGED; NEOPLASM STAGING; RECTAL NEOPLASMS; SERUM AMYLOID A PROTEIN;

EID: 84916920141     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2014.08.040     Document Type: Article

References (41)

1. R. Siegel, D. Naishadham, and A. Jemal Cancer statistics, 2013 CA Cancer J Clin 63 2013 11
2. R. Sauer, H. Becker, and W. Hohenberger Preoperative versus postoperative chemoradiotherapy for rectal cancer N Engl J Med 351 2004 1731
3. A. Karantanas, S. Yarmenitis, N. Papanikolaou, and N. Gourtsoyiannis Preoperative imaging staging of rectal cancer Dig Dis 25 2007 20
4. X. Wang, D. Lv, and H. Song Multimodal preoperative evaluation system in surgical decision making for rectal cancer: a randomized controlled trial Int J Colorectal Dis 25 2010 351
5. E. Malle, and F. De Beer Human serum amyloid A (SAA) protein: a prominent acute phase reactant for clinical practice Eur J Clin Invest 26 1996 427
6. I. Glojnarić, M.-T. Časl, D. Šimić, and J. Lukač Serum amyloid A protein (SAA) in colorectal carcinoma Clin Chem Lab Med 39 2001 129
7. M. Aslam, K. Taylor, J. Pringle, and J. Jameson MicroRNAs are novel biomarkers of colorectal cancer Br J Surg 96 2009 702
8. C.-Z. Chen, L. Li, H.F. Lodish, and D.P. Bartel MicroRNAs modulate hematopoietic lineage differentiation science 303 2004 83
9. C.M. Croce, and G.A. Calin miRNAs, cancer, and stem cell division Cell 122 2005 6
10. M. Dillhoff, S.E. Wojcik, and M. Bloomston MicroRNAs in solid tumors J Surg Res 154 2009 349
11. L. He, J.M. Thomson, and M.T. Hemann A microRNA polycistron as a potential human oncogene Nature 435 2005 828
12. M. Gironella, M. Seux, and M.-J. Xie Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor development Proc Natl Acad Sci U S A 104 2007 16170
13. S. Jiang, H.-W. Zhang, and M.-H. Lu MicroRNA-155 functions as an OncomiR in breast cancer by targeting the suppressor of cytokine signaling 1 gene Cancer Res 70 2010 3119
14. H. Shibuya, H. Iinuma, R. Shimada, A. Horiuchi, and T. Watanabe Clinicopathological and prognostic value of microRNA-21 and microRNA-155 in colorectal cancer Oncology 79 2011 313
15. R.F. Thoeni Colorectal cancer: cross-sectional imaging for staging of primary tumor and detection of local recurrence Am J Roentgenology 156 1991 909
16. J. Vandesompele, K. De Preter, and F. Pattyn Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes Genome Biol 3 2002 research0034
17. L.G. Legres, A. Janin, C. Masselon, and P. Bertheau Beyond laser microdissection technology: follow the yellow brick road for cancer research Am J Cancer Res 4 2014 1
18. S. Wang, L. Wang, and T. Zhu Improvement of tissue preparation for laser capture microdissection: application for cell type-specific miRNA expression profiling in colorectal tumors BMC Genomics 11 2010 163
19. M.R. Emmert-Buck, R.F. Bonner, and P.D. Smith Laser capture microdissection Science 274 1996 998
20. R.F. Bonner, M. Emmert-Buck, and K. Cole Laser capture microdissection: molecular analysis of tissue Science 278 1997 1481
21. F. Fend, and M. Raffeld Laser capture microdissection in pathology J Clin Pathol 53 2000 666
22. O. Dworak Number and size of lymph nodes and node metastases in rectal carcinomas Surg Endosc 3 1989 96
23. S. Andreola, E. Leo, and F. Belli Manual dissection of adenocarcinoma of the lower third of the rectum specimens for detection of lymph node metastases smaller than 5 mm Cancer 77 1996 607
24. M. Bjelovic, V. Kalezic, and M. Petrovic Correlation of macroscopic and histological characteristics in the regional lymph nodes of patients with rectal and sigmoidal adenocarcinoma Hepatogastroenterol 45 1998 433
25. S.P. Mönig, S.E. Baldus, and T.K. Zirbes Lymph node size and metastatic infiltration in colon cancer Ann Surg Oncol 6 1999 579
26. T.Y. Liang, A. Gopinathan, and W.L.A. Bertrand Imaging paradigms in assessment of rectal carcinoma: loco-regional and distant staging Cancer Imaging 12 2012 290
27. V.R. Muthusamy, and K.J. Chang Optimal methods for staging rectal cancer Clin Cancer Res 13 2007 6877
28. E. Al-Sukhni, L. Milot, and M. Fruitman Diagnostic accuracy of MRI for assessment of T category, lymph node metastases, and circumferential resection margin involvement in patients with rectal cancer: a systematic review and meta-analysis Ann Surg Oncol 19 2012 2212
29. G. Brown Thin section MRI in multidisciplinary pre-operative decision making for patients with rectal cancer Br J Radiol 78 2005 S117
30. J. Evans, U. Patel, and G. Brown Rectal cancer: primary staging and assessment after chemoradiotherapy Semin Radiat Oncol 21 2011 169
31. J. Brush, K. Boyd, and F. Chappell The value of FDG positron emission tomography/computerized tomography (PET/CT) in pre-operative staging of colorectal cancer: a systematic review and economic evaluation Health Technol Assess 15 2011 1
32. S.H. Heo, J.W. Kim, S.S. Shin, Y.Y. Jeong, and H.K. Kang Multimodal imaging evaluation in staging of rectal cancer World J Gastroenterol 20 2014 4244
33. D.-C. Chan, C.-J. Chen, and H.-C. Chu Evaluation of serum amyloid A as a biomarker for gastric cancer Ann Surg Oncol 14 2007 84
34. R. Tomasini, A. Azizi SamiR, and M.J. Pebusque P53-dependent expression of the stress-induced protein (SIP) Eur J Cell Biol 81 2002 294
35. R. Tomasini, A.A. Samir, and A. Carrier TP53INP1s and homeodomain-interacting protein kinase-2 (HIPK2) are partners in regulating p53 activity J Biol Chem 278 2003 37722
36. S. Schwitalla, P.K. Ziegler, and D. Horst Loss of p53 in enterocytes generates an inflammatory microenvironment enabling invasion and lymph node metastasis of carcinogen-induced colorectal tumors Cancer Cell 23 2013 93
37. T. El-Hefnawy, S. Raja, and L. Kelly Characterization of amplifiable, circulating RNA in plasma and its potential as a tool for cancer diagnostics Clin Chem 50 2004 564
38. X.H. Zheng, C. Cui, X.X. Zhou, Y.X. Zeng, and W.H. Jia Centrifugation: an important pre-analytic factor that influences plasma microRNA quantification during blood processing Chin J Cancer 32 2013 667
39. A. Hammerle-Fickinger, I. Riedmaier, C. Becker, H.H. Meyer, M.W. Pfaffl, and S.E. Ulbrich Validation of extraction methods for total RNA and miRNA from bovine blood prior to quantitative gene expression analyses Biotechnol Lett 32 2010 35
40. J. Jarry, D. Schadendorf, C. Greenwood, A. Spatz, and L.C. van Kempen The validity of circulating microRNAs in oncology: five years of challenges and contradictions Mol Onc 8 2014 819
41. C.C. Pritchard, E. Kroh, and B. Wood Blood cell origin of circulating microRNAs: a cautionary note for cancer biomarker studies Cancer Prev Res 5 2012 492